Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema
Qingquan Wei,1,* Zhongqi Wan,2,* Yongcheng Hu,3,* Qing Peng1 1Department of Ophthalmology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai 200072, People’s Republic of China; 2School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu Province, Peo...
Main Authors: | Wei Q, Wan Z, Hu Y, Peng Q |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/cytokine-and-chemokine-profile-changes-in-patients-after-intravitreal--peer-reviewed-article-DDDT |
Similar Items
-
Efficacy of intravitreal injection of Conbercept in the treatment of diabetic macular edema
by: Chen Jiang, et al.
Published: (2018-02-01) -
Intravitreal injection of conbercept combined with triamcinolone acetonide for diabetic macular edema
by: Jun Li<sup>*</sup>, et al.
Published: (2019-03-01) -
Efficacy of intravitreal Conbercept injection for macular edema secondary to macular branch retinal vein occlusion
by: Ping-Li Zhu, et al.
Published: (2018-01-01) -
Effect of intravitreal injection of Conbercept with laser photocoagulation on diabetic macular edema
by: Qiu-Xia Li, et al.
Published: (2018-06-01) -
Intravitreal injection of Conbercept in the treatment of exudative age-related macular degeneration
by: Hong-Xia Niu, et al.
Published: (2018-09-01)